awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35196715-1D401A72-3DE6-4505-8541-BC3ADE0BE9FA
Q35196715-1D401A72-3DE6-4505-8541-BC3ADE0BE9FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35196715-1D401A72-3DE6-4505-8541-BC3ADE0BE9FA
New hormonal therapies for castration-resistant prostate cancer.
P2860
Q35196715-1D401A72-3DE6-4505-8541-BC3ADE0BE9FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35196715-1D401A72-3DE6-4505-8541-BC3ADE0BE9FA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
df34df1d7c3dc223b6b6855093b7879e2356a567
P2860
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.